Riskpilot← Back to searchSign inGet full accessGYNEKOLOG ELIN ØDEGAARD AS
ASActiveOrg 913862244Rosenborggata 15D, 0356 OsloMedical specialists activities · NACE 8622Est. 20141 employees
Revenue 2025
NOK 6,9M
+12% vs 2024
EBITDA margin
58.0%
+18% vs 2024
Equity ratio
53.1%
Financial strength
Net profit 2025
NOK 3,1M
+14% vs 2024
| Revenue | NOK 6,9M | +12% |
| EBITDA | NOK 4M | +18% |
| Net profit | NOK 3,1M | +14% |
| Total assets | NOK 6,4M | +22% |
| Equity | NOK 3,4M | +49% |
| Employees | 1 | — |
Legal name
GYNEKOLOG ELIN ØDEGAARD AS
Org number
913862244
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
7. juli 2014
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Gynekologisk diagnostikk og behandling.
Address
Rosenborggata 15D, 0356 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5 219 | 5 208 | 5 649 | 6 227 | 6 944 |
| Staff expenses | −926 | −936 | −1 178 | −973 | −1 040 |
| EBITDA | 2 617 | 2 573 | 2 683 | 3 400 | 4 024 |
| Depreciation & amort. | −301 | −301 | −205 | −40 | −160 |
| EBIT | 2 316 | 2 272 | 2 478 | 3 360 | 3 864 |
| Net financials | −0 | −0 | 32 | 83 | 112 |
| Profit before tax | 2 316 | 2 272 | 2 510 | 3 442 | 3 976 |
| Tax | 525 | 526 | 565 | 705 | 862 |
| Net profit | 1 791 | 1 746 | 1 945 | 2 737 | 3 115 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 569 | 4 212 | 4 203 | 5 223 | 6 398 |
| Equity | 1 855 | 1 601 | 1 546 | 2 283 | 3 397 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 714 | 2 612 | 2 658 | 2 940 | 3 000 |
| Total debt | 2 714 | 2 612 | 2 658 | 2 940 | 3 000 |
EBITDA margin
58.0%
This company
15.8%
Market median
+267% vs market
20212025
Equity ratio
53.1%
This company
38.2%
Market median
+39% vs market
20212025
Return on equity
91.7%
This company
18.4%
Market median
+398% vs market
20212025
Net profit margin
44.9%
This company
8.1%
Market median
+454% vs market
20212025
Asset turnover
1.09×
This company
1.12×
Market median
+3% vs market
20212025
Debt / equity
0.88×
This company
0.62×
Market median
+42% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2018 | |
| Board of Directors | 2018 | |
| Board of Directors | 2018 | |
| Board of Directors | 2018 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
GYNEKOLOG ELIN ØDEGAARD AS 
SMESTADGYNEKOLOGENE ASBoard members of GYNEKOLOG ELIN ØDEGAARD AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Elin Ødegaard | Chairman | 0 companies |
| Lars Ødegaard Bentsen | Board of Directors | 0 companies |
| Hanna Ødegaard Bentsen | Board of Directors | 0 companies |
| Inger Johanne Skjerve | Board of Directors | 0 companies |